BLOG / 🇺🇸 United States / broad market · · daily

US SEC Filings Daily Market Digest — October 08, 2026

Daily USA Market Intelligence

By Gunpowder Editorial ·

31 high priority 19 medium priority 50 total filings analysed

Executive Summary

Today's stream of 50 SEC filings for October 8, 2026 is dominated by routine foreign private issuer 6-Ks, monthly regulatory returns, and small-cap SPAC and capital-structure housekeeping, with only a handful of market-moving disclosures.

The clearest fundamental signals come from large-cap earnings and operating data: PepsiCo delivered a strong Q3 top line (+5.6% net revenue, +17% EPS) but cut full-year core EPS guidance sharply to +2.5-3.5% on input-cost inflation, while TSMC's September revenue rose 54.6% YoY (nine-month revenue +41.1%) despite a 0.6% sequential dip, and ChipMOS posted Q3 revenue up 36.7% YoY with only +0.2% month-over-month momentum in September. Deal activity is concentrated in Drilling Tools International's ~$81M cash plus 17.4M-share acquisition of Saltire/Foxley, which would lift Eastern Hemisphere exposure from ~18% to ~40% of pro forma revenue. Balance-sheet stress shows up in SolarMax (cash down 72.9% since December while receivables rose 37.2%) and in New ERA's $116M letter-of-credit funding that required cash collateral and warrant issuance. Insider flow is almost entirely small-lot purchases at TSMC, which carry low economic weight but signal internal confidence. Overall the day's read is mixed: strong year-over-year growth at mega-cap and Asian semis versus margin pressure and liquidity strain at smaller, financing-dependent issuers.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K · 13F · 10-Q · Form 4 · 425

Tracking the trend? Catch up on the prior US SEC Filings Daily Market Digest digest from September 30, 2026.

Investment Signals (11)

  • PepsiCo ↓ (BEARISH)
    ▲

    Q3 2026 net revenue +5.6% YoY to $25.274B and EPS +17% YoY to $2.23, but core operating margin contracted 35 bps to 16.9% and full-year core EPS guidance was cut from +5-7% to +2.5-3.5%

  • TSMC (BULLISH)
    ▲

    September 2026 revenue NT$511.9B, up 54.6% YoY, nine-month revenue NT$3.90T up 41.1%, though down 0.6% MoM from August

  • Q3 2026 revenue NT$8.40B up 36.7% YoY and 13.8% QoQ, but September only +0.2% MoM, signaling sequential flattening

  • TSMC insiders (BULLISH)
    ▲

    Ten officers and controllers (including EVP/Co-COO Chin Yung-Pei and SVP/Deputy Co-COO Hou Yung-Chin) bought small lots at NT$79.39-equivalent, all within one filing window, signaling broad internal conviction

  • Acquisition of Saltire/Foxley for ~£60.3M cash plus 17.36M shares (~30% dilution) expands Eastern Hemisphere from ~18% to ~40% of pro forma revenue and is described as immediately accretive to Adjusted EBITDA margin and Adjusted FCF per share

  • ▲

    Repurchased 21.6M shares between Oct 1 and Oct 7 at weighted average prices of €11.75-€12.47, with 14.4M executed on Madrid, indicating an active, ongoing buyback

  • ▲

    CSL Plasma to complete NexSys PCS/Persona PLUS rollout at all current U.S. collection centers by end-2027, with fiscal 2027 guidance held and financial impact update promised at the November 2026 Q2 FY27 call

  • ▲

    Director Qi Dave holds 305,762 ADS after converting 1,563 shares, and director Tam Benson Bing Chung holds 257,984 after a similar conversion, reflecting routine equity-compensation flows rather than open-market conviction

  • Cash fell from $7.97M to $2.16M (-72.9%) while receivables rose 37.2% to $17.76M and convertible notes were issued, signaling a working-capital squeeze

  • Funded a $116M standby letter of credit for PowerCo's Luminant PPA with $118.3M cash collateral (partly from $60M new term-loan borrowings) and issued warrants on 413,055 shares at ~$7.26, while the TCDC data center still lacks any signed hyperscale lease

  • ▲

    Repurchased restricted stock awards for ~$2.7M at $9,634.09/share, including $530K from the CEO and $1.03M from the Chairman, ahead of the sale to Express Wellness Group, with XWELL now owning 100% of XpresTest

Risk Flags (9)

  • ▼

    Full-year core EPS guidance lowered to +2.5-3.5% from +5-7% despite Q3 organic revenue +3.1%, citing input-cost inflation and need for additional structural cost reductions; core margin down 35 bps to 16.9%

  • Cash and equivalents down 72.9% (from $7,966,797 to $2,158,233) over six months while accounts receivable rose 37.2% and the company issued convertible notes, raising dilution and collection risk

  • $60M of new term-loan borrowing plus $58.3M of cash on hand were needed to collateralize a $116M L/C; the data center strategy has shifted from a JV to direct leasing with no hyperscale tenant signed yet, and the company expects to refinance the term loan

  • Issuing ~30% of outstanding shares plus ~$81M cash requires stockholder approval, an S-4 effectiveness, Nasdaq listing approval, and a long-stop date of March 31, 2027; Eastern Hemisphere mix shift to ~40% raises FX, geopolitical, and integration risk

  • $151.1M trust established after a September 21, 2026 IPO, yet the auditor flagged substantial doubt about going-concern status and the company has no identified target, with an 18-month deadline to complete a business combination

  • Securities purchase agreement with Dune Equity Holdings imposes a D&O insurance purchase within 60 days, a broker-dealer non-assertion covenant, and a $3,000/day penalty for late 8-K filing after MNPI disclosure; covenant breach is an Event of Default

  • Valion Bio (Tivic Health)/Related-Party Financing [MEDIUM RISK]
    ▼

    Small $50,000 Series B tranche from 3i, LP with conditional closing tied to Nasdaq compliance; continued reliance on related-party capital and emerging-growth status signal ongoing funding strain

  • Six 8-K items in one filing including change of control, unregistered equity sales, and amendments to articles, with no quantified terms disclosed; the absence of transaction size or counterparty names limits diligence

  • PRA Group/Leverage↓ [LOW-MEDIUM RISK]
    ▼

    Completed a $400M aggregate principal debt offering on October 2, 2026, adding to the direct financial obligation load without disclosed use of proceeds in the filing

Opportunities (8)

  • Pro forma international mix moving to ~40% and management describes the deal as immediately accretive to Adjusted EBITDA margin and Adjusted FCF/share; a 24-month lock-up on seller stock supports near-term float discipline

  • TSMC/Demand Momentum (OPPORTUNITY)
    ◆

    September revenue +54.6% YoY and nine-month revenue +41.1% YoY, with insider buying across ten officers at a common price point, suggests management views the cycle as intact even after a 0.6% sequential dip

  • Q3 revenue +36.7% YoY with 13.8% QoQ expansion, yet monthly growth has flattened to +0.2%, creating a potential entry point if October revenue re-accelerates

  • Roughly 21.6M shares repurchased in one trading week (about 3M per day) across four venues, with pricing band €11.75-€12.47, offering persistent bid support and visibility into capital return pace

  • CSL's end-2027 rollout of NexSys PCS and Persona PLUS across all current U.S. centers creates a recurring disposables revenue runway; the November 2026 earnings call is the next checkpoint for quantifying financial impact

  • XWELL/Sale Completion↓ (OPPORTUNITY)
    ◆

    With XWELL now owning 100% of XpresTest and the buyer's price fixed at $9,634.09/share for RSAs, the pending sale to Express Wellness Group is closer to clean closing, reducing dilution risk around the transaction

  • ◆

    With full-year core EPS guidance reset to +2.5-3.5% and YTD net income up 46.6% on lapping prior impairments, a valuation re-set could offer entry if structural cost savings prove credible

  • Acquired Saltire (founded 1986, bases in UK, Norway, UAE, Singapore, Malaysia) adds regional footprint in a sector where Eastern Hemisphere demand is a key driver of pricing; a March 2027 closing creates a dated catalyst

Sector Themes (6)

  • Strong Asia Semiconductor Growth Versus Sequential Stall (BULLISH)
    ◆

    TSMC (+54.6% YoY September, nine-month +41.1%) and ChipMOS (Q3 +36.7% YoY) both show robust annual growth, but September/Q3 sequential momentum is flat (TSMC -0.6% MoM, ChipMOS +0.2% MoM), suggesting the cycle is maturing even as year-over-year comparisons remain elevated

  • Consumer Staples Margin Squeeze (BEARISH)
    ◆

    PepsiCo's core margin contracted 35 bps and guidance was cut on input-cost inflation, illustrating how commodity and cost pressure is compressing staples margins despite pricing and FX tailwinds; the pattern warrants monitoring across packaged food peers

  • Financing-Dependent Small Caps (BEARISH)
    ◆

    SolarMax (cash -72.9%), New ERA (L/C secured with borrowed cash and warrants), Valion Bio (related-party tranche), and Eva Live (covenant-heavy convertible) all show capital-intensive models relying on dilutive or insider-linked financing, a recurring theme in micro-cap filings today

  • SPAC Activity Continues Despite Going-Concern Flags (NEUTRAL)
    ◆

    Leader's Advantage ($151.1M trust), Texas Ventures III ($250K sponsor note), FortuneX, DT Cloud Star (Cayman charter amendment) and Quetta (adjourned vote to Oct 9) show an active SPAC pipeline where sponsor support and deadline pressure drive filings more than operations

  • International Foreign Private Issuer Filings (NEUTRAL)
    ◆

    Routine 6-K disclosures from Bilibili, Noah, HDFC Bank, Woodside, argenx, Costamare, and Ryde reflect regulatory cadence (monthly returns, postal ballots, AGM outcomes) rather than material events, providing low signal content

  • Insider Activity Mix (BULLISH)
    ◆

    Open-market purchases at TSMC (ten officers, small lots) contrast with compensation-driven conversions at Hello Group, illustrating that today's insider signal is positive in tone but economically modest; no large sales were disclosed

Watch List (8)

  • Monitor whether the reset core EPS guide (+2.5-3.5%) holds given rising input costs and the structural cost program; any further cut would extend the margin pressure narrative [Date not specified in filing]

  • Registration statement due within 45 days (around November 22, 2026), with stockholder meeting to follow; long-stop closing date is March 31, 2027 [Q1 2027 target]

  • Refinancing of the Term Loan Agreement is expected in the near term; watch for any hyperscale lease announcement for the Texas Critical Data Center project [Near term, date not specified]

  • Management will quantify financial impact of the CSL NexSys/Persona PLUS rollout on the November 2026 call; watch for any fiscal 2027 guidance change [November 2026]

  • TSMC/October Monthly Revenue
    👁

    Next monthly revenue release will show whether the September sequential dip (-0.6% MoM) reverses; ongoing insider buying at a common price point may foreshadow sentiment [Early November 2026 release, approximate]

  • Going-concern opinion and 18-month deadline; watch for any announced target or extension request [Ongoing, deadline approximately March 2028]

  • Stockholder meeting adjourned from October 8 to October 9, 2026 at 4:00 p.m. ET to allow more proxy solicitation; vote outcome will be known within 24 hours [October 9, 2026]

  • Weekly 6-K disclosures will reveal whether the approximately 3M-share-per-day repurchase pace continues through October [Ongoing, weekly filings]

Filing Analyses (50)
Addex Therapeutics Ltd. 6-K neutral materiality 1/10

08-10-2026

Addex Therapeutics Ltd filed a Form 6-K with the SEC on October 8, 2026, attaching a press release of the same date. The filing incorporates the press release by reference into its existing registration statements. The report also includes a standard risk factors reminder and is signed by CEO Tim Dyer. No specific financial results, material events, or operational updates are disclosed in the filing itself.

  • · The press release is dated October 8, 2026.
  • · The filing incorporates the press release by reference into Form F-3 (Registration No. 333-291644) and Form S-8 (Registration No. 333-255124 and No. 333-272515).
  • · The company's Annual Report on Form 20-F for the year ended December 31, 2025 was filed on May 15, 2026.
CHIPMOS TECHNOLOGIES INC 6-K positive materiality 6/10

08-10-2026

ChipMOS Technologies reported September 2026 monthly revenue of NT$2,792.0 million (US$87.7 million), up 0.2% month-over-month and 33.8% year-over-year. For the third quarter of 2026, consolidated revenue reached NT$8,400.8 million (US$263.8 million), a 13.8% sequential increase and a 36.7% year-over-year gain. The results show strong annual growth but only marginal monthly improvement.

  • · September 2026 revenue was NT$2,792.0 million (US$87.7 million), compared to NT$2,785.7 million (US$87.5 million) in August 2026 and NT$2,087.4 million (US$65.5 million) in September 2025.
  • · Third quarter 2026 revenue was NT$8,400.8 million (US$263.8 million), compared to NT$7,383.1 million (US$231.8 million) in Q2 2026 and NT$6,143.7 million (US$192.9 million) in Q3 2025.
  • · Month-over-month growth in September was only 0.2%, indicating a near-flat sequential trend despite strong annual comparisons.
Bilibili Inc. 6-K neutral materiality 10/10

08-10-2026

Bilibili Inc. filed a Form 6-K with the SEC on October 8, 2026, reporting the submission of a monthly return to The Stock Exchange of Hong Kong Limited regarding movements in its authorized share capital and issued shares during September 2026. The filing is a routine regulatory disclosure and does not contain any financial results or material operational updates.

  • · Filing date: October 8, 2026
  • · Reporting period: September 2026
  • · Commission File Number: 001-38429
  • · Exhibit 99.1 – Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules
Ryde Group Ltd 6-K neutral materiality 5/10

08-10-2026

Ryde Group Ltd filed a Form 6-K with the SEC on October 8, 2026, furnishing its unaudited condensed consolidated financial statements for the six months ended June 30, 2026, along with management's discussion and analysis and a press release. The filing covers the first half of 2026 results and provides corporate updates. The report is incorporated by reference into the company's registration statements.

  • · The filing includes three exhibits: unaudited financial statements (Exhibit 99.1), MD&A (Exhibit 99.2), and a press release (Exhibit 99.3).
  • · The report is incorporated by reference into the company's Form F-3 (No. 333-288587) and Form S-8 (Nos. 333-278873 and 333-284900) registration statements.
  • · The company is a foreign private issuer based in Singapore, with its principal executive offices at Duo Tower, 3 Fraser Street, #08-21 Singapore 189352.
NOAH HOLDINGS LTD 6-K neutral materiality 5/10

08-10-2026

Noah Holdings Limited filed a Form 6-K with the SEC on October 8, 2026, reporting its monthly return for equity issuers and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules. The filing is a routine regulatory disclosure and contains no financial results or material business developments.

  • · Filing date: October 8, 2026
  • · Commission File Number: 001-34936
  • · Registrant address: 333 North Bridge Road, #05-11 Odeon 333, Singapore 188721
New ERA Energy & Digital, Inc. 8-K mixed materiality 8/10

08-10-2026

New ERA Energy & Digital, Inc. (NUAIW) entered into a Letter of Credit Reimbursement Agreement with Macquarie Bank Limited on October 7, 2026, securing a $116.0 million standby letter of credit for its subsidiary PowerCo's obligations under a Power Purchase Agreement with Luminant. The obligations are secured by cash collateral of at least $118.3 million (102% of the undrawn amount), funded partly by $60.0 million in new borrowings under an existing Term Loan Agreement and $58.3 million from cash on hand. The company also issued warrants to the lender for 413,055 shares at ~$7.26 per share and has shifted its strategy for the Texas Critical Data Center project from a joint venture to direct leasing with hyperscale tenants, though no leases have been secured yet.

  • · The company has shifted its strategy for the TCDC Project from a joint venture with a data center developer to directly negotiating leases with hyperscale tenants.
  • · The company expects to refinance the outstanding borrowings under the Term Loan Agreement in the near future.
  • · The Reimbursement Agreement contains standard representations, warranties, covenants, and events of default.
  • · The warrants were issued under an exemption from registration pursuant to Section 4(a)(2) of the Securities Act of 1933.
PRUDENTIAL FINANCIAL INC 8-K neutral materiality 3/10

08-10-2026

Prudential Financial, Inc. (PRS) filed a Form 8-K on October 8, 2026, disclosing under Item 7.01 (Regulation FD) and Item 9.01, with the report date of October 8, 2026. The filing is a routine Regulation FD disclosure with no financial results, operational metrics, or material corporate developments included in the provided content. The filing primarily covers administrative details of the 8-K submission, including registered securities such as Common Stock (PRU) and three series of Junior Subordinated Notes (PRH, PRS, PFH).

  • · Filing is an 8-K Current Report filed under Section 13 or 15(d) of the Securities Exchange Act of 1934
  • · Report date: October 8, 2026
  • · Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits) are covered
  • · Three classes of junior subordinated notes are registered: 5.950% (PRH), 5.625% (PRS), 4.125% (PFH)
WOODSIDE ENERGY GROUP LTD 6-K neutral materiality 1/10

08-10-2026

Woodside Energy Group Ltd filed a Form 6-K with the SEC on October 8, 2026, covering an ASX announcement titled 'Appendix 3G'. The filing is a routine foreign issuer report related to a change in corporate governance or securities issuance, with no financial details or performance metrics disclosed.

ARGENX SE 6-K neutral materiality 2/10

08-10-2026

ARGENX SE filed a Form 6-K with the SEC on October 8, 2026, as a foreign private issuer, attaching two press releases dated the same day. The filing is a routine regulatory disclosure and does not contain financial results or operational metrics.

  • · Filing date: October 8, 2026
  • · Two press releases (Exhibits 99.1 and 99.2) were furnished with the 6-K
  • · Signed by General Counsel Hemamalini (Malini) Moorthy
Ayalon Insurance Comp Ltd. 13F-HR neutral materiality 3/10

08-10-2026

Ayalon Insurance Comp Ltd. filed its quarterly 13F-HR report for the period ending September 30, 2026, disclosing 70 equity holdings with a total market value of approximately $1.2 million. The portfolio is heavily weighted toward ETFs, with the largest positions in Vanguard S&P 500 ETF, State Street Health Care Select Sector SPDR ETF, and State Street Technology Select Sector SPDR ETF. The filing reflects a diversified, passive investment approach with limited direct stock exposure.

  • · The portfolio is dominated by ETFs, with the top 10 holdings accounting for approximately 60% of total market value.
  • · The largest single stock position is NVIDIA Corp, valued at $23,192, followed by Meta Platforms ($15,519), Amazon.com ($11,714), Microsoft ($9,047), and Alphabet ($7,694).
  • · The filing includes a nominal position in Mobileye Global Inc with a market value of $0 and 1 share.
  • · The portfolio includes a mix of sector-specific ETFs (e.g., healthcare, technology, financials, energy) and thematic ETFs (e.g., cybersecurity, solar, uranium, semiconductors).
  • · The filing is signed by Avigdor Kaplan (Chairman) and Sharon Reich (CEO).
HDFC BANK LTD 6-K neutral materiality 1/10

08-10-2026

HDFC Bank Ltd filed a Form 6-K with the SEC on October 8, 2026, covering the month of October 2026, as a foreign private issuer. The filing includes a notice of postal ballot, indicating a shareholder voting matter. No financial figures or operational metrics were disclosed in this filing.

  • · Filing date: October 8, 2026
  • · Report covers month of October 2026
  • · Commission File Number: 001-15216
  • · Exhibit 99: Notice of Postal Ballot
BRINKS CO 8-K neutral materiality 2/10

08-10-2026

The Brink's Company (BCO) filed a Form 8-K on October 8, 2026, disclosing that it issued a press release under Item 8.01 (Other Events). The filing is a routine disclosure of the press release, attached as Exhibit 99.1, with no financial results or operational metrics included in the filing itself.

  • · Filing is an 8-K with Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
  • · Press release issued on October 8, 2026, attached as Exhibit 99.1
  • · Company headquarters: 1801 Bayberry Court, P.O. Box 18100, Richmond, VA 23226-8100
  • · Common stock trades on NYSE under ticker BCO, par value $1.00 per share
Tivic Health Systems, Inc. 8-K neutral materiality 5/10

08-10-2026

Valion Bio, Inc. (formerly Tivic Health Systems, Inc.) entered into a Third Side Letter with 3i, LP on October 7, 2026, agreeing to issue 50 Series B Preferred Shares and warrants for 1,539 common shares at $2.5520 per share for $50,000, under the existing Series B Preferred Purchase Agreement. This is a small incremental closing within a larger financing structure, with 3i retaining options to purchase additional Series B and Series C preferred shares. The company continues to rely on related-party financing, indicating ongoing capital needs.

  • · The securities were issued under an exemption from registration pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506(b).
  • · The closing is subject to conditions including compliance with Nasdaq listing requirements and delivery of price adjustment notices.
  • · The company is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.
  • · The company changed its name from Tivic Health Systems, Inc. to Valion Bio, Inc. (name change date: September 10, 2019).
Eva Live Inc 8-K neutral materiality 7/10

08-10-2026

Eva Live Inc. entered into a Securities Purchase Agreement with Dune Equity Holdings LLC on October 2, 2026, for the sale of securities (likely a convertible note). The agreement includes covenants requiring the company to purchase D&O insurance within 60 days of closing, maintain irrevocable transfer agent instructions, and not assert that the buyer is a broker-dealer. Breach of covenants constitutes an event of default under the Note, and the company must pay $3,000 per day if it fails to file an 8-K after disclosing material non-public information to the buyer.

  • · Company must purchase D&O insurance within 60 days of closing for 18 months with 2-year tail coverage.
  • · Company covenants not to assert that Buyer is a broker-dealer under the Securities Exchange Act of 1934.
  • · Breach of covenants is an Event of Default under Section 3.3 of the Note.
  • · Transfer agent instructions are irrevocable; company must provide resolutions within 6 hours of each conversion.
  • · Arbitration of claims in Delaware; exclusive venue for litigation is state or federal court in Delaware.
  • · Conditions to Buyer's obligation include no Material Adverse Effect, no trading suspension by SEC/FINRA, and delivery of good standing certificates.
Distribution Solutions Group, Inc. 8-K neutral materiality 3/10

08-10-2026

Distribution Solutions Group, Inc. (DSGR) filed a Form 8-K on October 7, 2026, announcing a dividend via Regulation FD disclosure. The filing includes a solicitation material checkbox under Rule 14a-12, indicating the announcement may relate to an upcoming shareholder vote. No financial figures were disclosed in the filing.

  • · Filing is an 8-K dated October 7, 2026, filed under Items 7.01 (Regulation FD Disclosure) and 9.01
  • · Company announced a dividend on October 7, 2026
  • · Common stock trades on NASDAQ Global Select Market under ticker DSGR
  • · Company is incorporated in Delaware with principal offices in Fort Worth, Texas
Quetta Acquisition Corp 8-K neutral materiality 3/10

08-10-2026

Quetta Acquisition Corporation (QETAR) filed an 8-K on October 7, 2026, announcing that its special meeting of stockholders, originally scheduled for October 8, 2026, will be convened and then immediately adjourned to October 9, 2026, to allow more time for proxy solicitation. The record date remains September 22, 2026, and previously submitted proxies will remain valid. The filing does not disclose any financial results or performance metrics, so no positive or negative trends can be assessed.

  • · Special meeting adjourned from October 8, 2026 at 4:00 p.m. ET to October 9, 2026 at 4:00 p.m. ET.
  • · Record date for the special meeting is September 22, 2026.
  • · Proxies previously submitted remain valid unless properly revoked.
Texas Ventures Acquisition III Corp 8-K neutral materiality 5/10

08-10-2026

Texas Ventures Acquisition III Corp (TVACW) entered into a $250,000 promissory note with its sponsor, Yorkville Acquisition Sponsor II, LLC, on September 30, 2026. The note is non-interest bearing, due upon the earlier of the initial business combination or winding up, and is convertible into units of the post-combination entity at $10.00 per unit at the payee's option. The sponsor has waived any claim against the trust account, with repayment to come from trust proceeds only upon consummation of the business combination.

  • · The note is non-interest bearing and the principal is due on the earlier of the initial business combination or winding up.
  • · Conversion option allows the payee to convert all or part of the note into New Units at $10.00 per unit, with terms identical to private placement units from the IPO.
  • · The sponsor waives any claim against the trust account; repayment is only from trust proceeds released upon the business combination.
  • · Default triggers include failure to pay within 5 business days, voluntary bankruptcy, or involuntary bankruptcy with a 60-day grace period.
NEXTNRG, INC. 8-K neutral materiality 2/10

08-10-2026

NextNRG, Inc. filed an 8-K on October 8, 2026, disclosing the adoption of its Articles of Incorporation under Nevada law (NRS Chapter 78), appointing Michael D. Farkas as incorporator and Corporate Creations Network Inc. as registered agent. The filing is a routine corporate formation document with no financial results, operational metrics, or forward-looking guidance. No monetary amounts, revenue figures, or performance data are disclosed in this filing.

  • · Incorporator: Michael D. Farkas, 407 Lincoln Rd. #9F, Miami Beach, Florida 33190
  • · Registered agent: Corporate Creations Network Inc., 8275 South Eastern Avenue #200, Las Vegas, NV 89123
  • · Corporation formed under Nevada Revised Statutes (NRS), Chapter 78
XWELL, Inc. 8-K neutral materiality 6/10

08-10-2026

XWELL, Inc. subsidiary XpresTest repurchased 279.5 restricted stock awards for ~$2.7M ($9,634.09/share) on October 8, 2026, including shares held by Chairman Bruce T. Bernstein ($1.03M), CEO Ezra T. Ernst ($529,874.94), and CFO Ian Brown ($96,340.90). The repurchases simplify XpresTest's capitalization ahead of the previously announced sale of XpresSpa and XpresTest to Express Wellness Group, LLC. After the repurchases, XWELL owns 100% of XpresTest's outstanding capital stock.

  • · The repurchase price of $9,634.09 per share matches the per-share price agreed with the Buyer under the Securities Purchase Agreement dated July 6, 2026.
  • · The repurchases were completed early with the Buyer's consent to simplify XpresTest's capitalization in preparation for the Sale.
  • · All amounts paid for the repurchased RSAs would have reduced the purchase price dollar-for-dollar as sale expenses; since paid early, they will not be included in unpaid sale expenses.
  • · After the repurchases, no XpresTest RSAs remain outstanding.
  • · XWELL now owns all issued and outstanding shares of XpresTest capital stock.
NEWS CORP 8-K neutral materiality 3/10

08-10-2026

News Corp filed an 8-K on October 8, 2026, disclosing daily repurchase transaction information provided to the Australian Securities Exchange (ASX) under its existing $1 billion stock repurchase program. The filing reiterates the company's authorization to repurchase up to $1 billion in aggregate of its Class A and Class B common stock, but does not report any specific repurchase activity or financial results.

  • · The repurchase program authorizes up to $1 billion in aggregate of Class A and Class B common stock.
  • · Disclosure is made under ASX rules on a daily basis for any transactions under the program.
  • · The filing includes forward-looking statements regarding the company's intent to repurchase shares from time to time.
  • · Exhibits 99.1 and 99.2 contain the information provided to the ASX on the respective dates.
Oil-Dri Corp of America 8-K neutral materiality 4/10

08-10-2026

Oil-Dri Corp of America (ODC) entered into a Ninth Amendment to its existing Credit Agreement with BMO Bank N.A., dated October 7, 2026. The amendment modifies the terms of the January 27, 2006 credit agreement, with the Company representing no Default or Event of Default exists and reaffirming its guarantees. No new borrowing amounts or financial figures were disclosed in the filing.

  • · Amendment dated October 7, 2026 to the existing Credit Agreement originally dated January 27, 2006
  • · Amendment is between Oil-Dri Corporation of America and BMO Bank N.A.
  • · Amendment amends the Existing Credit Agreement, excluding schedules and exhibits other than Exhibit A (Revolving Note) and Exhibit B (Compliance Certificate)
  • · Company represents no Default or Event of Default exists under the Existing Credit Agreement, the Amended Credit Agreement or any other Loan Document
GENERAL DYNAMICS CORP 8-K neutral materiality 6/10

08-10-2026

General Dynamics announced that its board elected Danny Deep, currently president, to become CEO effective January 1, 2027, succeeding Phebe Novakovic, who will transition to executive chairman after serving as CEO since 2013. Deep has been with the company for 25 years and became president in 2025. The company employs more than 120,000 people worldwide and generated $52.6 billion in revenue in 2025.

  • · Danny Deep has been with General Dynamics for 25 years, serving in roles including president (2025), EVP of Global Operations, EVP of Combat Systems, and president of Land Systems
  • · Phebe Novakovic has served as CEO since 2013 and will transition to executive chairman
  • · General Dynamics generated $52.6 billion in revenue in 2025
  • · General Dynamics employs more than 120,000 people worldwide
Marquie Group, Inc. 8-K neutral materiality 5/10

08-10-2026

Marquie Group, Inc. filed a multi-item 8-K on October 8, 2026, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to security holder rights (Item 3.03), a change in control (Item 5.01), director/officer departures and appointments (Item 5.02), and amendments to articles of incorporation (Item 5.03). The filing indicates a comprehensive corporate restructuring involving a change of control, new leadership, and equity issuance, but no specific financial metrics, transaction values, or named parties are disclosed. The lack of quantitative data limits assessment of materiality and market impact.

  • · Filing includes 6 separate 8-K items, indicating a complex event
  • · No financial statements or pro forma data provided (Item 9.01 exhibits not detailed)
  • · No specific names of new directors/officers or departing individuals disclosed in summary
  • · No transaction value, share count, or percentage changes mentioned
  • · No scheduled events (e.g., shareholder meeting, earnings call) referenced
PRA GROUP INC 8-K neutral materiality 5/10

08-10-2026

PRA Group, Inc. (PRAA) completed a $400 million aggregate principal amount debt offering on October 2, 2026, as previously announced. The offering was disclosed under Items 1.01 (Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation), and 9.01 (Financial Statements and Exhibits) of Form 8-K. No specific financial performance metrics were provided in this filing.

  • · Debt offering of $400M aggregate principal amount completed on October 2, 2026
  • · Filing is an 8-K with Items 1.01 (Material Definitive Agreement), 2.03 (Creation of Financial Obligation), and 9.01 (Financial Statements)
DT Cloud Star Acquisition Corp 8-K neutral materiality 2/10

08-10-2026

DT Cloud Star Acquisition Corporation (DTSQU) filed an 8-K on October 8, 2026, disclosing the adoption of its Fourth Amended and Restated Memorandum and Articles of Association, passed by special resolution on October 1, 2026. The amendment updates the company's constitutional documents under Cayman Islands law, including provisions on the registered office, objects, corporate capacity, and licensed business restrictions. No financial results or operational metrics were disclosed in this filing.

  • · Fourth Amended and Restated Memorandum and Articles of Association adopted by special resolution on 1 October 2026
  • · Registered office: Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands
  • · Company is a Cayman Islands exempted company limited by shares with unrestricted objects and corporate capacity
  • · Company restricted from banking, insurance, and company management businesses without proper licensing
FortuneX Acquisition Corp 8-K/A neutral materiality 3/10

08-10-2026

FortuneX Acquisition Corp filed Amendment No. 1 to its Form 8-K on October 8, 2026, disclosing entry into a material agreement (Item 1.01) with a report date of September 18, 2026. The company is a Cayman Islands-incorporated blank check company listed on Nasdaq, and the filing includes written communications under Rule 425. No financial figures were disclosed in this amendment.

  • · Warrants are exercisable for one ordinary share at an exercise price of $11.50 per share
  • · Each unit consists of one ordinary share and one-half of one warrant
  • · Company address: 1185 Avenue of the Americas, 3rd Fl., New York, NY 10036
Leader's Advantage Acquisition Corp. 8-K mixed materiality 8/10

08-10-2026

Leader's Advantage Acquisition Corp. consummated its IPO on September 21, 2026, selling 15,000,000 units at $10.00 per unit for gross proceeds of $150,000,000, with $151,125,000 placed in a trust account. Simultaneously, it completed private sales of shares and warrants to underwriters and sponsor, raising an additional $5,431,250. However, the company's auditor has issued a going concern opinion, noting the SPAC lacks capital resources to fund operations for a reasonable period and must complete a business combination within 18 months, while it has not yet identified any target or commenced substantive discussions.

  • · The company is a blank check company (SPAC) incorporated in the Cayman Islands on October 29, 2025, and has not commenced any operations.
  • · The company has not selected any specific Business Combination target and has not engaged in any substantive discussions with any target.
  • · The auditor's report includes an explanatory paragraph about substantial doubt regarding the company's ability to continue as a going concern due to lack of capital resources to fund operations for a reasonable period (generally one year from the financial statement issuance date).
  • · Class A ordinary shares subject to possible redemption: 15,000,000 shares at redemption value of $10.075 per share, totaling $151,125,000.
  • · Shareholders' deficit is $5,830,707, driven by an accumulated deficit of $5,831,157.
  • · The company must complete a business combination with target(s) having a fair market value of at least 80% of the net balance in the Trust Account.
  • · The company will only complete a business combination if it acquires 50% or more of the outstanding voting securities or a controlling interest in the target.
PEPSICO INC 8-K mixed materiality 9/10

08-10-2026

PepsiCo reported Q3 2026 net revenue of $25.274B, up 5.6% YoY, and EPS of $2.23, up 17% YoY. Organic revenue grew 3.1%, driven by international strength and improved North America convenient foods volume trends. However, core operating margin contracted 35 bps to 16.9%, core EPS growth was only 2%, and the company sharply lowered its full-year core EPS guidance from +5-7% to +2.5-3.5%, citing rising input cost inflation and the need for additional structural cost reductions.

  • · Q3 2026 net revenue growth of 5.6% included a 1.7-ppt net benefit from acquisitions/divestitures and a 0.7-ppt benefit from FX translation.
  • · Q3 2026 organic revenue growth of 3.1% reflected effective net pricing and a contribution from organic volume growth.
  • · Q3 2026 operating profit growth of 19% was driven by a favorable net impact of acquisition/divestiture charges and mark-to-market gains on commodity derivatives.
  • · Core operating margin contracted 35 bps in Q3 and 25 bps YTD, reflecting operating cost increases and higher advertising and marketing expenses.
  • · PFNA operating profit declined 13% in Q3 and 8% YTD.
  • · PBNA volume declined 6% in both Q3 and YTD; PBNA organic revenue declined 2% in Q3 and 3% YTD.
  • · International segments (IB Franchise, EMEA, LatAm Foods, Asia Pacific Foods) all delivered strong net revenue growth with organic volume growth.
  • · Fiscal 2026 guidance revised: organic revenue narrowed to ~+3% (from +2-4%), core constant currency EPS lowered to +1-2% (from low-end +4-6%), core EPS lowered to +2.5-3.5% (from low-end +5-7%).
  • · Capital spending guided below 5% of net revenue; free cash flow conversion ratio at least 80%.
  • · Cash returns to shareholders of $8.9B unchanged ($7.9B dividends + $1.0B buybacks).
SolarMax Technology, Inc. 10-Q neutral materiality 7/10

08-10-2026

SolarMax Technology, Inc. (SMXT) reported a 10-Q for the quarter ended June 30, 2026, showing cash and cash equivalents of $2,158,233, down from $7,966,797 at December 31, 2025, while accounts receivable increased to $17,759,110 from $12,939,589. The company also issued convertible notes during the period, reflecting ongoing capital needs.

  • · Cash and cash equivalents decreased from $7,966,797 (Dec 31, 2025) to $2,158,233 (Jun 30, 2026), a 72.9% decline
  • · Accounts receivable increased 37.2% from $12,939,589 (Dec 31, 2025) to $17,759,110 (Jun 30, 2026)
PEPSICO INC 10-Q positive materiality 9/10

08-10-2026

PepsiCo reported strong financial results for the 12 and 36 weeks ended September 5, 2026, with net revenue increasing 5.6% to $25.274B for the quarter and 6.7% to $68.898B year-to-date. Net income attributable to PepsiCo rose 17.1% to $3.048B (quarter) and 46.6% to $8.356B (year-to-date), driven by operating profit growth and the absence of prior-year impairment charges. However, the company experienced a significant net currency translation loss of $858M in the quarter (vs. a $39M gain a year ago), and operating cash flow improved to $7.950B from $5.468B, while net cash used for financing activities increased to $3.904B from $1.008B.

  • · Segment operating profit for the 12 weeks ended 9/5/2026: PFNA $1.333B, PBNA $1.056B, IB Franchise $0.562B, EMEA $0.897B, LatAm Foods $0.624B, Asia Pacific Foods $0.174B.
  • · Corporate unallocated expenses for the 12 weeks ended 9/5/2026 were $386M.
  • · Net currency translation adjustment for the 12 weeks ended 9/5/2026 was a loss of $858M, compared to a gain of $39M in the prior year.
  • · Cash dividends paid during the 36 weeks ended 9/5/2026 were $5.935B, up from $5.692B in the prior year.
  • · Share repurchases during the 36 weeks ended 9/5/2026 were $739M, slightly down from $752M in the prior year.
  • · Capital spending for the 36 weeks ended 9/5/2026 was $2.182B, down from $2.499B in the prior year.
  • · Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets were $148M for the 36 weeks ended 9/5/2026, compared to $3.176B in the prior year.
  • · Total assets increased to $111.976B as of September 5, 2026, from $107.399B as of December 27, 2025.
  • · Total equity increased to $22.487B as of September 5, 2026, from $20.547B as of December 27, 2025.
  • · Diluted EPS for the 12 weeks ended 9/5/2026 was $2.23, up from $1.90 in the prior year; for the 36 weeks ended 9/5/2026, diluted EPS was $6.10, up from $4.15.
Hello Group Inc. 4 neutral materiality 4/10

08-10-2026

Director Tam Benson Bing Chung exercised/converted 1,563 American Depositary Shares. 6 transactions reported in total. Tam Benson Bing Chung holds 257,984 shares after the transaction.

  • · Director Tam Benson Bing Chung exercised/converted 1,563 American Depositary Shares
  • · Director Tam Benson Bing Chung exercised/converted 1,563 American Depositary Shares
  • · Director Tam Benson Bing Chung exercised/converted 1,563 American Depositary Shares
  • · Director Tam Benson Bing Chung exercised/converted 3,126 Restricted Share Units
  • · Director Tam Benson Bing Chung exercised/converted 3,126 Restricted Share Units
  • · Director Tam Benson Bing Chung exercised/converted 3,126 Restricted Share Units
Hello Group Inc. 4 neutral materiality 4/10

08-10-2026

Director Qi Dave exercised/converted 1,563 American Depositary Shares. 6 transactions reported in total. Qi Dave holds 305,762 shares after the transaction.

  • · Director Qi Dave exercised/converted 1,563 American Depositary Shares
  • · Director Qi Dave exercised/converted 1,563 American Depositary Shares
  • · Director Qi Dave exercised/converted 1,563 American Depositary Shares
  • · Director Qi Dave exercised/converted 3,126 Restricted Share Units
  • · Director Qi Dave exercised/converted 3,126 Restricted Share Units
  • · Director Qi Dave exercised/converted 3,126 Restricted Share Units
Drilling Tools International Corp 425 neutral materiality 9/10

08-10-2026

Drilling Tools International Corp (DTI) entered into a Share Purchase Agreement on October 8, 2026 to acquire the entire issued share capital of Saltire Energy Limited and Foxley Energy Limited (the 'Group') for aggregate consideration of approximately £60.3 million in cash (about $81 million) plus 17,355,139 shares of DTI common stock (expected to represent about 30% of outstanding shares post-closing). The transaction is subject to stockholder approval, SEC effectiveness of a registration statement, and Nasdaq listing approval, with a long-stop closing date of March 31, 2027. The Sellers are subject to a 24-month lock-up on the equity consideration, and DTI must file a registration statement within 45 days and hold a stockholder meeting to approve the share issuance.

  • · The Buyer is Casing Technologies Group Limited, a wholly owned subsidiary of DTI.
  • · The Sellers include individuals and trustees of The Loggie Family Trust and Cansco Limited Employee Trust 2007.
  • · The Trustee Seller (Cansco trust) receives its consideration entirely in cash; other Sellers receive a greater portion in stock.
  • · There is no escrow, earnout, or post-closing true-up.
  • · The Company's board recommendation to stockholders cannot be withdrawn or modified in favor of a superior proposal (no fiduciary out).
  • · If stockholder approval is not obtained, the Company must adjourn the meeting for up to 30 days.
  • · The Buyer has obtained a warranty and indemnity insurance policy; premium split 50/50 between Buyer and Sellers; Buyer bears retention.
  • · Financing for the cash consideration is expected from new debt and borrowings under DTI's existing credit facility.
  • · The Sellers' aggregate liability for warranty claims and most tax indemnity claims is capped at £1.
  • · The Sellers' aggregate liability for certain excluded tax claims is capped at £2,500,000.
  • · The tax warranties and tax indemnities survive for five years following Closing (or longer for Romanian tax liability).
  • · Leakage claims survive for 12 months.
  • · The Lock-up and Investor Rights Agreement includes an early release mechanism and limitations on sales volume and prohibited transferees.
  • · The Seller Representative has the right to designate either a board member or a non-voting board observer, subject to ownership thresholds.
Drilling Tools International Corp 8-K mixed materiality 9/10

08-10-2026

Drilling Tools International Corp. (DTI) announced a definitive agreement to acquire Saltire Energy Limited and Foxley Energy Limited for approximately $80 million in cash and 17.4 million shares of DTI common stock. The transaction is expected to close in Q1 2027 and is projected to be immediately accretive to Adjusted EBITDA margins and Adjusted Free Cash Flow per share. While the acquisition significantly expands DTI's Eastern Hemisphere presence from ~18% to ~40% of pro forma revenue, it introduces integration risks and increased indebtedness, and the fixed share consideration may dilute existing shareholders.

  • · Saltire was founded in 1986 and has operating bases in the UK, Norway, UAE, Singapore, and Malaysia.
  • · The share consideration is fixed at 17.4 million shares and will not be adjusted for changes in DTI's stock price before closing.
  • · The sellers' shares will be subject to lock-up arrangements described in the Form S-4 registration statement.
  • · DTI expects to fund the cash consideration through new debt financing and borrowings under its existing credit facility.
  • · The transaction is subject to customary regulatory approvals, closing conditions, and DTI stockholder approval.
  • · Mike Loggie and all members of Saltire's management team will remain with the combined company post-close.
  • · DTI will file a registration statement on Form S-4 with the SEC containing additional transaction details.
  • · A conference call is scheduled for October 8, 2026, at 9:00 a.m. ET to discuss the acquisition.
HAEMONETICS CORP 8-K positive materiality 7/10

08-10-2026

Haemonetics disclosed that CSL Plasma expects to complete the rollout of its NexSys PCS devices with Persona PLUS technology and related disposables at all of CSL's current U.S. plasma collection centers by the end of calendar year 2027. The company did not update its fiscal 2027 guidance, noting that scope and timing remain subject to change, and expects to provide an update on the anticipated financial impact during its Q2 FY27 earnings call in November 2026.

  • · CSL expects to complete the rollout by the end of calendar year 2027.
  • · The transition is anticipated to occur at all of CSL's current U.S. plasma collection centers.
  • · Haemonetics is not updating its previously issued fiscal 2027 guidance at this time.
  • · An update on the anticipated impact on fiscal 2027 financial results is expected in connection with the Q2 FY27 earnings call in November 2026.
  • · The supply agreement is non-exclusive and was initially disclosed on August 18, 2026.
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 6-K positive materiality 8/10

08-10-2026

TSMC reported September 2026 consolidated net revenue of NT$511,857 million, a 54.6% year-over-year increase but a slight 0.6% month-over-month decline from August 2026. For the first nine months of 2026, cumulative revenue reached NT$3,898,727 million, up 41.1% from the same period in 2025, reflecting strong demand despite the sequential monthly dip.

  • · September 2026 net revenue of NT$511,857,399 thousand (exact value) vs NT$330,980,920 thousand in September 2025
  • · January-September 2026 cumulative net revenue of NT$3,898,726,974 thousand vs NT$2,762,963,851 thousand in the prior year
  • · Month-over-month revenue declined 0.6% from August 2026 (NT$514,806 million), indicating a slight sequential slowdown
Banco Santander, S.A. 6-K neutral materiality 3/10

08-10-2026

Banco Santander disclosed the repurchase of 21,600,000 of its own shares (SAN) between October 1 and October 7, 2026, across four trading venues (XMAD, CEUX, TQEX, AQEU), as part of its ongoing buyback program. The weighted average purchase prices ranged from €11.75 to €12.47 per share, with the largest volumes executed on the Madrid exchange (XMAD). The filing is a routine disclosure of share buyback activity under the foreign issuer reporting framework.

  • · Largest single-day repurchase was on 01/10/2026 with 7,400,000 shares (weighted avg price €12.03).
  • · Smallest daily volume was on 06/10/2026 with 1,200,000 shares (weighted avg price €12.47).
  • · XMAD (Madrid) accounted for the majority of repurchases, totaling 14,389,206 shares.
  • · Weighted average prices ranged from €11.75 (02/10/2026, XMAD) to €12.47 (06/10/2026, XMAD).
  • · Repurchase activity declined sharply from 7.4M shares on 01/10 to 1.2M on 06/10, before recovering to 2.8M on 07/10.
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 4 positive materiality 3/10

08-10-2026

SVP and Deputy Co-COO Hou Yung-Chin bought 60 Common Shares (2330.TW) at $79.39 (~$4.76K). Hou Yung-Chin holds 60 shares after the transaction.

  • · SVP and Deputy Co-COO Hou Yung-Chin bought 60 Common Shares (2330.TW) at $79.39 (~$4.76K)
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 4 positive materiality 2/10

08-10-2026

VP Hsu Kuo-Chin bought 52 Common Shares (2330.TW) at $79.39 (~$4.13K). Hsu Kuo-Chin holds 6,781 shares after the transaction.

  • · VP Hsu Kuo-Chin bought 52 Common Shares (2330.TW) at $79.39 (~$4.13K)
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 4 positive materiality 4/10

08-10-2026

VP He Jun bought 43 Common Shares (2330.TW) at $79.39 (~$3.41K). He Jun holds 45 shares after the transaction.

  • · VP He Jun bought 43 Common Shares (2330.TW) at $79.39 (~$3.41K)
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 4 positive materiality 4/10

08-10-2026

VP Chuang Tzu-Sou bought 46 Common Shares (2330.TW) at $79.39 (~$3.65K). Chuang Tzu-Sou holds 47 shares after the transaction.

  • · VP Chuang Tzu-Sou bought 46 Common Shares (2330.TW) at $79.39 (~$3.65K)
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 4 positive materiality 2/10

08-10-2026

VP Cao Min bought 51 Common Shares (2330.TW) at $79.39 (~$4.05K). Cao Min holds 6,824 shares after the transaction.

  • · VP Cao Min bought 51 Common Shares (2330.TW) at $79.39 (~$4.05K)
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 4 positive materiality 3/10

08-10-2026

EVP and Co-COO Chin Yung-Pei bought 67 Common Shares (2330.TW) at $79.39 (~$5.32K). Chin Yung-Pei holds 8,573 shares after the transaction.

  • · EVP and Co-COO Chin Yung-Pei bought 67 Common Shares (2330.TW) at $79.39 (~$5.32K)
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 4 positive materiality 4/10

08-10-2026

SVP Chang Tzonz-Sheng bought 51 Common Shares (2330.TW) at $79.39 (~$4.05K). Chang Tzonz-Sheng holds 52 shares after the transaction.

  • · SVP Chang Tzonz-Sheng bought 51 Common Shares (2330.TW) at $79.39 (~$4.05K)
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 4 positive materiality 2/10

08-10-2026

SVP and GC Fang Shu-Hua bought 53 Common Shares (2330.TW) at $79.39 (~$4.21K). Fang Shu-Hua holds 6,761 shares after the transaction.

  • · SVP and GC Fang Shu-Hua bought 53 Common Shares (2330.TW) at $79.39 (~$4.21K)
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 4 positive materiality 4/10

08-10-2026

VP Chuang Juiping bought 46 Common Shares (2330.TW) at $79.39 (~$3.65K). Chuang Juiping holds 48 shares after the transaction.

  • · VP Chuang Juiping bought 46 Common Shares (2330.TW) at $79.39 (~$3.65K)
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 4 positive materiality 2/10

08-10-2026

VP Chen Pei-Hung bought 43 Common Shares (2330.TW) at $79.39 (~$3.41K). Chen Pei-Hung holds 1,438 shares after the transaction.

  • · VP Chen Pei-Hung bought 43 Common Shares (2330.TW) at $79.39 (~$3.41K)
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 4 positive materiality 3/10

08-10-2026

Controller Chen Chih-Ho bought 31 Common Shares (2330.TW) at $79.39 (~$2.46K). Chen Chih-Ho holds 233 shares after the transaction.

  • · Controller Chen Chih-Ho bought 31 Common Shares (2330.TW) at $79.39 (~$2.46K)
Perspective Therapeutics, Inc. 8-K neutral materiality 3/10

08-10-2026

Perspective Therapeutics, Inc. (NYSE American: CATX) filed a Form 8-K on October 8, 2026, announcing via press release that it is providing an update under Item 8.01 (Other Events). The filing contains no financial results, no operational metrics, and no forward-looking guidance — it is a routine disclosure of a corporate update.

  • · Filing is an 8-K with Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
  • · Press release issued October 8, 2026
  • · Company headquarters: 2401 Elliott Avenue, Suite 320, Seattle, WA 98121
  • · Trading symbol: CATX on NYSE American LLC
  • · Common stock par value: $0.001 per share
Costamare Bulkers Holdings Ltd 6-K neutral materiality 2/10

08-10-2026

Costamare Bulkers Holdings Limited filed a Form 6-K with the SEC on October 8, 2026, reporting the election of a Class I director at its 2026 Annual Meeting of Stockholders. The filing incorporates a press release dated October 8, 2026, and contains no financial results or operational metrics.

  • · The Form 6-K is filed under Commission File Number 001-42581.
  • · The registrant's principal executive office is located at 7 rue du Gabian, MC 98000 Monaco.
  • · The company files annual reports under Form 20-F.
  • · Exhibit 99.1 is incorporated by reference into the company's Form F-3 registration statement (File No. 333-287685) filed May 30, 2025.

Get daily alerts with 11 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US SEC Filings Daily Market Digest

🇺🇸 More from United States

View all →